Companies related to Metabolic disease

Advancing peptides for the treatment of rare endocrine and related diseases

#researchneverstops

Australia’s first Microbiome Research Centre delivering world-class research on the microbiome in human health.

Enabling Success

Any Assay, Anywhere, Any Area. A Global Leader for Services in Drug R&D Enabling.

Fast-track your pipeline with preclinical excellence. in vitro & in vivo research services since 1991.

Because Your Health is Our Priority

🔹 Premier Positions. Premier Talent. Premier Pharma. 🔹

Al Servicio de la Salud

Excellence, Accuracy, Reliability

Madrigal is focused on developing therapeutics to improve the lives of patients with metabolic and fatty liver diseases.

The Journal of Inherited Metabolic Disease (JIMD) is the official journal of the SSIEM.

The New Gold Standard in Community Research